PRMT5 indirectly regulates RNA methylation and is synthetically lethal with MTAP deletion, a common alteration in drug-tolerance cells with pancreatic, lung, and bladder cancers 135, 136. The gene discussed is PRMT5; the disease is urinary bladder carcinoma.